Modus Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Modus Advisors's LLY Position: Q1 2026 in Review
Modus Advisors increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $802K and bringing the position to 4,162 shares worth $3.83M. The position accounts for 1.05% of the portfolio, ranked #39.
Modus Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Modus Advisors held 4,162 shares of Eli Lilly worth $3.83M as of Q1 2026.
- Modus Advisors bought 791 Eli Lilly shares in Q1 2026, an estimated $802K.
- Eli Lilly made up 1.05% of Modus Advisors's portfolio in Q1 2026, its #39 holding.
- Modus Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.